checkAd
    Startseite > Aktien > Ocular Therapeutix > Nachrichten
    Ocular Therapeutix Aktie
    5,5150
     
    USD
    +9,86 %
    +0,4950 USD
    Letzter Kurs 17:16:19 Nasdaq
    5,5100
     
    USD
    500 STK
    Geldkurs 17:16:25
    5,5200
     
    USD
    100 STK
    Briefkurs 17:16:25
    ISIN: US67576A1007 · WKN: A1180P · SYM: OCUL · USA

    Neueste Nachrichten

    Ocular Therapeutix to Host Investor Day in New York City on Thursday, June 13, 2024
    01.05.24 · globenewswire · Ocular Therapeutix
    Fokus Aktien mit extremen Handelsvolumen am Donnerstag, den 18.04.2024
    18.04.24 · wO Chartvergleich · Exponent
    Ocular Therapeutix Announces Positive Topline Phase 1 Data for AXPAXLI in Diabetic Retinopathy
    18.04.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix Strengthens Clinical Team with Appointment of Key Retinal Leaders
    16.04.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessich is Stepping Down as President and CEO
    15.04.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Senior Vice President of Global Head of Biometrics
    09.04.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix Announces Positive Phase 2 PAXTRAVA Glaucoma Data at the American Society of Cataract and Refractive Surgery 2024 Annual Meeting
    06.04.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix To Present Data at the 2024 ASCRS Annual Meeting (American Society of Cataract and Refractive Surgery)
    26.03.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix Reports Fourth Quarter and Full Year 2023 Results
    11.03.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix to Release Fourth Quarter and Full Year 2023 Results on March 11, 2024
    05.03.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Chairman and Chief Strategy Officer
    22.02.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix, Inc. Announces $325.0 Million Private Placement
    22.02.24 · globenewswire · Ocular Therapeutix